High-content drug screening with engineered musculoskeletal tissues
about
Electrical stimulation as a biomimicry tool for regulating muscle cell behaviorCreating living cellular machinesMicrofabricated mammalian organ systems and their integration into models of whole animals and humansMicrofluidic device for the formation of optically excitable, three-dimensional, compartmentalized motor unitsFormation and optogenetic control of engineered 3D skeletal muscle bioactuators.In vitro Differentiation of Functional Human Skeletal Myotubes in a Defined SystemBiomimetic engineered muscle with capacity for vascular integration and functional maturation in vivoA high throughput mechanical screening device for cartilage tissue engineering.A multiplexed chip-based assay system for investigating the functional development of human skeletal myotubes in vitroUsing physiologically-based pharmacokinetic-guided "body-on-a-chip" systems to predict mammalian response to drug and chemical exposureRoles of adherent myogenic cells and dynamic culture in engineered muscle function and maintenance of satellite cellsComplex interactions between human myoblasts and the surrounding 3D fibrin-based matrix.Skeletal muscle tissue engineering: methods to form skeletal myotubes and their applications.Mechanistic investigation of adult myotube response to exercise and drug treatment in vitro using a multiplexed functional assay systemBiomimetic 3D Tissue Models for Advanced High-Throughput Drug Screening.Serotonin and Histamine Therapy Increases Tetanic Forces of Myoblasts, Reduces Muscle Injury, and Improves Grip Strength Performance of Dmd(mdx) Mice.Microfluidic heart on a chip for higher throughput pharmacological studies.Simple silicone chamber system for in vitro three-dimensional skeletal muscle tissue formation.Creating Interactions between Tissue-Engineered Skeletal Muscle and the Peripheral Nervous System.Integrating in vitro organ-specific function with the microcirculation.In vitro myoblast motility models: investigating migration dynamics for the study of skeletal muscle repair.Skeletal muscle tissue engineering: strategies for volumetric constructs.Biomimetic scaffolds for regeneration of volumetric muscle loss in skeletal muscle injuries.Generation of human muscle fibers and satellite-like cells from human pluripotent stem cells in vitro.Muscular dystrophy in a dish: engineered human skeletal muscle mimetics for disease modeling and drug discovery.High-Content Assessment of Cardiac Function Using Heart-on-a-Chip Devices as Drug Screening Model.A contactless electrical stimulator: application to fabricate functional skeletal muscle tissue.Interdigitated array of Pt electrodes for electrical stimulation and engineering of aligned muscle tissue.Decoupling cell and matrix mechanics in engineered microtissues using magnetically actuated microcantilevers.Endothelial Network Formation Within Human Tissue-Engineered Skeletal MuscleCharacterization and optimization of a simple, repeatable system for the long term in vitro culture of aligned myotubes in 3D.Microfibers as Physiologically Relevant Platforms for Creation of 3D Cell Cultures.Tailored Approaches in Drug Development and Diagnostics: From Molecular Design to Biological Model Systems.A real-time monitoring platform of myogenesis regulators using double fluorescent labeling.Three-dimensional co-culture of C2C12/PC12 cells improves skeletal muscle tissue formation and function.An Assessment of Myotube Morphology, Matrix Deformation, and Myogenic mRNA Expression in Custom-Built and Commercially Available Engineered Muscle Chamber Configurations.Engineering of Human Skeletal Muscle With an Autologous Deposited Extracellular Matrix
P2860
Q26826818-6943B764-A7F7-42DA-B81E-79B0801AB9D6Q26865923-8CAB6F8C-BAD4-48B9-94BF-F266356DDC4CQ27011459-31A8FFA6-A698-47FB-9292-0B37CFA5A293Q27334752-C49C6EDA-82D9-483F-BAFE-E7CB38B371C4Q30537019-ABC6FBA5-C620-44A5-9EFC-BBD7545F1478Q30571229-1050B13A-F854-43E3-81DD-814BE76E0192Q30576471-9ED1FE0D-0BD4-4178-927A-850A88716B6EQ33584043-1D6271DA-A9DF-46AC-90D8-28D2E5B4FFC1Q34053670-1D72F650-AE65-493F-8A51-6B76D861560AQ34143269-6F47446E-E8E8-452C-9302-8444BF1901BFQ34146576-3304698E-4478-44E6-BB62-08BD61122108Q34257262-5A76A04C-E715-46AD-9F6B-FD112B6A6193Q34322871-FC743616-F005-4612-B0D6-42EC80948AF0Q34626889-F38B1774-197F-43D2-B8C4-C8671233DAA1Q35694549-5BAA8B43-B186-4064-A7E0-E7EC71916FB3Q36371908-7DCB12EA-FFF1-4ED3-8F84-F8A5B2A39FA6Q37205939-FE951553-60CD-4CE3-AEE4-D39D4730005AQ37348573-2437C600-5BB6-4F7A-94CE-F8E0FE85B136Q37522846-3CFD3FEC-BB0F-4075-968D-E996366D46B7Q37691970-9DA2464E-65CE-40A3-B299-0DBA51AA886EQ38154819-FBF0820A-810A-49D4-B7DC-E38638CBA231Q38258077-58FA3201-BB79-4A53-B335-2232F32C988BQ38556395-D270469C-1B6A-49EC-84C4-BE1723B3F828Q38748704-F43BDE88-5BE1-4FC6-A721-F4F28C84FFB9Q38816248-B2D407E1-F391-49AB-9F7B-1139CB0A54C7Q39253982-046622B3-99C3-4312-90DA-D49923206B76Q39281515-35423B2A-DAC8-40B9-9482-D2E3E0D31D13Q39305483-A96BA548-5491-4958-8CB5-6FCC4E4B1E80Q40025681-CB6E2136-4362-4F8F-8FA4-C2CDF8E5FE0AQ42592508-D010967C-04B5-4A81-AF82-ABDE8846139DQ45029860-06CA7BD6-CEAA-4B30-9927-73E09503664FQ47338418-323F5A24-15AD-479D-AB09-F049B423F8D2Q47690085-C29266CF-826E-49E3-8A92-B4EB9754ADD7Q50000068-33174836-7508-4500-A2C3-0EB102472AB9Q53392849-D9DF11F2-952E-47C4-B01E-2086F213CE42Q55193920-6A7C1ACC-71F6-4716-8677-3C2200D3F4B8Q58735394-0AC70401-F8B8-42E3-AD71-EF83D2045C11
P2860
High-content drug screening with engineered musculoskeletal tissues
description
2010 nî lūn-bûn
@nan
2010 թուականի Փետրուարին հրատարակուած գիտական յօդուած
@hyw
2010 թվականի փետրվարին հրատարակված գիտական հոդված
@hy
2010年の論文
@ja
2010年論文
@yue
2010年論文
@zh-hant
2010年論文
@zh-hk
2010年論文
@zh-mo
2010年論文
@zh-tw
2010年论文
@wuu
name
High-content drug screening with engineered musculoskeletal tissues
@ast
High-content drug screening with engineered musculoskeletal tissues
@en
type
label
High-content drug screening with engineered musculoskeletal tissues
@ast
High-content drug screening with engineered musculoskeletal tissues
@en
prefLabel
High-content drug screening with engineered musculoskeletal tissues
@ast
High-content drug screening with engineered musculoskeletal tissues
@en
P2860
P1476
High-content drug screening with engineered musculoskeletal tissues
@en
P2093
Herman Vandenburgh
P2860
P356
10.1089/TEN.TEB.2009.0445
P577
2010-02-01T00:00:00Z